Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric Philadelphia chromosome-positive chronic myeloid leukemia imatinib study
2007-001339-69Phase 4Active
- Sponsor
- Technische Universität Dresden
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of imatinib in chronic myelogenous leukemia (CML), sponsored by Technische Universität Dresden. Primary endpoints: Rate of hematological remissions, Rate of cytogenetical remissions and 1 more. Started Feb 2008; status: active.
02
Drugs
03
Conditions
chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on 2007-001339-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001339-69.